Assessment of in vitro antimicrobial activities of ceftolozane/tazobactam and ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Salem D.; El-Shenawy A.; Dahroug H.; Zaiton M.; Gamal D.; Diab M.

Journal: BMC Infectious Diseases

Publisher: BioMed Central Ltd

Publication Date: 28 April 2025

Volume / Issue: Volume 25 / Issue 1

Article No.: 622

ISSN: 14712334

DOI: 10.1186/s12879-025-10891-w

Scopus: View on Scopus

PubMed: 40295988

Document Type: Article

Access: All Open Access; Gold Open Access; Green Open Access


Authors and Affiliations

Salem D., Microbiology Department, Theodor Bilharz Research Institute (TBRI), P.O Box 12411, Postal Address: 30 Imbaba, Giza, Egypt; El-Shenawy A., Microbiology Department, Theodor Bilharz Research Institute (TBRI), P.O Box 12411, Postal Address: 30 Imbaba, Giza, Egypt; Dahroug H., Microbiology Department, Theodor Bilharz Research Institute (TBRI), P.O Box 12411, Postal Address: 30 Imbaba, Giza, Egypt; Zaiton M., Microbiology Department, Theodor Bilharz Research Institute (TBRI), P.O Box 12411, Postal Address: 30 Imbaba, Giza, Egypt; Gamal D., Microbiology Department, Theodor Bilharz Research Institute (TBRI), P.O Box 12411, Postal Address: 30 Imbaba, Giza, Egypt; Diab M., Microbiology Department, Theodor Bilharz Research Institute (TBRI), P.O Box 12411, Postal Address: 30 Imbaba, Giza, Egypt


Abstract

Background: Carbapenem resistant Pseudomonas aeruginosa (P. aeruginosa) is a global health concern that poses a challenge to treat in health care facilities. Ceftazidim/avibactam and ceftolozane/tazobactam have a potential role in treatment of multi-drug resistant phenotypes including carbapenem resistant P. aeruginosa. Therefore, we aimed to assess the in vitro antimicrobial activity of ceftazidime/avibactam and ceftolozane/tazobactam against carbapenem-resistant P. aeruginosa (CRPA) strains with different β-lactamase/carbapenemase genes. Methods: Sixty CRPA isolates identified from clinical samples were examined for antimicrobial susceptibility including ceftazidim/avibactam and ceftolozane/tazobactam by Vitek2 compact system, and carbapenemase production by modified carbapenem inactivation method (mCIM) test and carbapenemase producing genes by polymerase chain reaction (PCR). Results: Isolates were resistant to imipenem in 96.7% and meropenem in 88.3%. of isolates. Carbapenemase production by mCIM test was 70% compared to 73.3% by (PCR). Carbapenemase encoding genes blaNDM, blaVIM and blaOXA-48 were detected in 60%, 41.7% and 25% respectively while blaIMP and blaKPC weren’t identified in this study. Among CRPA, both ceftazidim/avibactam and ceftolozane/tazobactam; were sensitive in only 11.7% of the isolates. Resistance to ceftazidim/avibactam and ceftolozane/tazobactam in isolates owning blaNDM, blaVIM, blaOXA-48 and those having combined blaNDM, blaVIM and blaOXA-48 carbapenemase resistance genes were 97.2%, 92%, 100% and 100% respectively. Conclusion: Modified carbapenem inactivation method test gave satisfactory results and could be used as an alternative to expensive genotypic methods. Ceftazidim/avibactam and ceftolozane/tazobactam were unsuccessful against carbapenem resistant P. aeruginosa isolates carrying carbapenemase genes especially metallo-β lactamase genes. Therefore, it is essential to detect susceptibility patterns to newly introduced β-Lactam/β-Lactamase inhibitor combinations due to the emerging resistance to these therapeutics. © The Author(s) 2025.


Keywords

Carbapenem resistant P. aeruginosa; Ceftazidim/avibactam; Ceftolozane/tazobactam; Modified carbapenem inactivation method test; β-Lactam/β-Lactamase inhibitor combinations; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; amikacin; avibactam plus ceftazidime; aztreonam; carbapenemase; cefepime; ceftolozane plus tazobactam; ceftriaxone; ciprofloxacin; extended spectrum beta lactamase; gentamicin; imipenem; meropenem; metallo beta lactamase; piperacillin plus tazobactam; ticarcillin; timentin; tobramycin; antiinfective agent; avibactam, ceftazidime drug combination; azabicyclo derivative; bacterial protein; beta lactamase; carbapenem derivative; ceftolozane, tazobactam drug combination; cephalosporin derivative; antibiotic sensitivity; antimicrobial activity; Article; bacterial gene; bacterial strain; bacterium isolation; blaIMP gene; blaKPC gene; blaNDM gene; blaOXA 48 gene; blaVIM gene; carbapenem resistant Pseudomonas aeruginosa; genotype; in vitro study; minimum inhibitory concentration; nonhuman; polymerase chain reaction; drug combination; drug effect; genetics; human; isolation and purification; microbial sensitivity test; microbiology; multidrug resistance; Pseudomonas infection


Citation Information

Scopus Citations: 5


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region